aminoguanidine optic nerve neuroprotection enzyme

more news on aminoguanidine

Submitted by Agnes on Fri, 07/10/2009 - 6:39pm

NO to Glaucoma

By Sean Henahan, Access Excellence
 


St. Louis, MO (8.19.99)- A new neuroprotective approach aimed at blocking the synthesis of nitric oxide may offer the hope of new treatments for glaucoma, a leading cause of blindness in the world.

Subscribe to FitEyes.com RSS Feed Subscribe to aminoguanidine optic nerve neuroprotection enzyme